VRBCF (Virbac) Scaled Net Operating Assets : 0.65 (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Virbac Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Virbac's operating assets for the quarter that ended in Dec. 2024 was $1,779 Mil. Virbac's operating liabilities for the quarter that ended in Dec. 2024 was $522 Mil. Virbac's Total Assets for the quarter that ended in Jun. 2024 was $1,934 Mil. Therefore, Virbac's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.65.

Virbac Scaled Net Operating Assets Historical Data

The historical data trend for Virbac's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Scaled Net Operating Assets Chart

Virbac Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.49

0.54

0.59

0.66

0.79

Virbac Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.57	0.65	0.61	0.84	0.65

Competitive Comparison of Virbac's Scaled Net Operating Assets

For the Drug Manufacturers - General subindustry, Virbac's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Virbac's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Virbac's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Virbac's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Virbac Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Virbac's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2024 )
=	(Operating Assets (A: Dec. 2024 )	-	Operating Liabilities (A: Dec. 2024 ))	/	Total Assets (A: Dec. 2023 )
=	(1778.943	-	521.577)	/	1587.492
=	0.79

where

	Operating Assets		(A: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1935.625	-	156.682
=	1778.943

	Operating Liabilities		(A: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	843.057	-	255.787	-	65.693
=	521.577

Virbac's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2024 )
=	(Operating Assets (Q: Dec. 2024 )	-	Operating Liabilities (Q: Dec. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(1778.943	-	521.577)	/	1933.511
=	0.65

where

	Operating Assets		(Q: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1935.625	-	156.682
=	1778.943

	Operating Liabilities		(Q: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	843.057	-	255.787	-	65.693
=	521.577

Virbac Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Virbac's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

VIRPp:UK 0NM7:UK VIRP:France V16:Germany

Address

13e rue LID - BP 27, Carros, FRA, 06511

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.